Fatty acid composition and CD36 expression in breast adipose tissue of premenopausal and postmenopausal women

Anticancer Research

Volumn 17, Issue 2 A, 1997, Pages 1217-1221

  Abbadia, Z ^a   Vericel, E ^b   Mathevet, P ^a   Bertin, N ^a   Panaye, G ^a   Frappart, L ^a  

^a EDOUARD HERRIOT HOSPITAL   (France)

^b INSERM   (France)

Author keywords

Adipocyte; CD36 fatty acid; Human breast cancer

Indexed keywords

ARACHIDONIC ACID; CD36 ANTIGEN; ICOSANOID; LONG CHAIN FATTY ACID; POLYUNSATURATED FATTY ACID;

ADIPOCYTE; ADIPOSE TISSUE; ADULT; AGED; ARTICLE; BREAST; BREAST CANCER; BREAST EPITHELIUM; CELL DIFFERENTIATION; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; FATTY ACID TRANSPORT; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LIPID COMPOSITION; POSTMENOPAUSE; PREMENOPAUSE; PRIORITY JOURNAL; RISK FACTOR;

ADIPOSE TISSUE; ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD36; BREAST; BREAST NEOPLASMS; FATTY ACIDS; FEMALE; HUMANS; MIDDLE AGED; POSTMENOPAUSE; PREMENOPAUSE; TRIGLYCERIDES;

EID: 0030981834     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Oka TM, Yoshimura M, Lavadero S, Wada K and Ohba Y: Control of growth and differentiation of mammary gland by growth factors. J Diary Sc 74: 2788-2800, 1990.
2. Imagawa W, Bandyopadhyay GK and Naudi S: Regulation of mammary epithelial cell growth in mice and rats. Endocrinol Rev 11: 494-523, 1990.
3. Sigurdson SL and Ip MM: Casein accumulation by rat mammary epithelial cells grown within a reconstituted basement membrane is modulated by fatty acids in a hormone- and time-dependent manner. Exp Cell Res 208: 333-343, 1993.
4. Rose PD and Connolly JM: Stimulation of growth of human breast cancer cell lines in culture by linoleic acid. Biochem Biophys Res Commun 164: 277-283, 1989.
5. Rose DP and Connolly JM: Effect of fatty acids and inhibition of eicosanoid synthesis on the growth of a human breast cancer cell lines in culture. Cancer Res 50: 7139-7144, 1990..
6. Hubbard NE and Erickson KL.: Effect of dietary linoleic acid level on lodgement, proliferation and survival of mammary tumor metastases. Cancer Lett 44: 117-125, 1989.
7. Hubbard NE and Erickson KL: Role of dietary oleic acid in linoleic acid enhanced metastasis of a mouse mammary tumor. Cancer Lett 56:165-171, 1991.
8. Chajes J, Niyongabo T, Lanson M, Fignon A, Covet C, and Bougnoux P: Fatty-acid composition of breast and iliac adipose tissue in breast cancer patients. Int J Cancer 50: 405-408, 1992.
9. Welsch CW: Enhancement of mammary tumorigenesis by dietary fat: review of potential mechanisms. Am J Clin Nutr 47: 6171-6175, 1987.
10. Rebbuffe-scrive M, Eldh J, Hafstron L and Bjornlorp P: Metabolism of mammary abdominal and femoral adipocytes in women before and after menopause. Metabolism 35: 792-797, 1986.
11. Asch AS, Barnwell J, Silverstein RL and Nachman RL: Isolation of the thrombospondin membrane receptor. J Clin Invest 79: 1054-1061, 1987.
12. Pechoux C, Clezardin P, Danle R, Serre CM, Bertin N and Frappart L: Localisation of thrombospondin, CD36 and CD51 during prenatal development of the human mammary gland. Differentiation 57: 133-141, 1994.
13. Endermann G, Stanton LW, Madden KS, Bryant CM, White RT and Protter AA: CD36 is a receptor for oxidized low density lipoprotein. J Biol Chem 205: 11811-11816, 1993.
14. Abumrad NA, El-Maghrabi MR, Amri EZ, Lopez E and Grimaldi PA: Cloning of a rat adipocyte membrane protein implicated in binding or transport of long-chain fatty acids that is induced during preadipocyte differentiation. J Biol Chem 265: 17665-17668, 1993.
15. Tandon NN, Lipsky RH and Burgess WH: Isolation and characterisation of platelet glycoprotein IV (CD36). J Biol Chem 264: 7570-7575, 1989.
16. Greenwalt DE, Scheck SH and Rhinehart-Jones T: Heart CD36 expression is increased in murine models of diabetes and in mice fed a high fat diet. J Clin Chem 259: 8945-8953, 1995.
17. Abumrad NA, Park JH and Park CR: Permeation of long-chain fatty acid into adipocytes. J Biol Chem 259: 8945-8953, 1984.
18. Oka T and Voshimura M: Paracrine regulation of mammary gland growth. Clin Endocrinol Metab 15: 79-97, 1986
19. Ip C: Fat and essential fatty acid in mammary carcinogenesis. Am J Clin Nutr 45: 218-224, 1987.
20. Bligh FG and Dyer WJ: A rapid method of total lipid extraction and purification. J Biochem Physiol 37: 911-917, 1959.
21. Bowyer DE, Leat WM, Howard AN and Greshon GA: The determination of the fatty acid composition of serum lipids separate by thin layer chromatography and comparison with column chromatography. Biochem Biophys Acta 70: 423-431, 1963.
22. Abbadia Z, Amiral J, Trzeciak MC, Delmas PD and Clezardin P: The growth-supportive effect of thrombospondin and the expression of TSP by human MG-63 ostcoblastic cells are both inhibited by dexamethasone. FEES Lett 335: 161-166, 1993b.
23. Abbadia Z, Clezardin P, Serre CM, Amiral J and Delmas PD: Thrombospondin mediates in vitro proliferation of human MG-63 osteoblastic cells induced by α-thrombin. FEBS Lett 329: 341-346, 1993a.
24. Naundorf H, Zschiesche W, Reszka R and Fichtner I: Influence of Liposomes rich in unsaturated or saturated fatty acids on the growth of human xenotransplanted mammary carcinomas and on the levels of heart type fatty acid binding protein. In vivo 9: 247-252, 1995.
25. Karmali RA: Eicosanoids and cancer. Prog Clin Biol Res 222: 687-697, 1986.
26. Honn KV, Bockman RS and Marnett LJ: Prostaglundins and cancer: a review of tumor initiation through metastasis. Prostaglundins 21: 833-864, 1981.
27. Kamp F and Hamilton JA: Movement of fatty acid analogues, and bile acids across phospholipid bilayers, Biochemistry 32: 11074-11086, 1993.
28. Clezardin P, Frappart L and Peehoux C: Expression of thrombospondin (TSP I) and its receptor (CD36, CD51) in normal, hyperplastic and neoplastic human breast. Cancer Res 53: 1-10, 1993.
29. Dawes J, Clezardin P and Pratt DA: Thrombospondin in milk, other breast secretions, and breast tissue. Semin Thromb Hemostasis 13: 378-384, 1987.
30. Pratt DA, Miller WR and Dawes J: Thrombospondin in malignant and nonmalignant breast tissue. Eur J Cancer Clin Oncol 25: 343-350, 1989.
31. O'Shea KS and Dixit VM: Unique distribution of the extracellular matrix component thrombospondin in the developing mouse embryo. J Cell Biol 107: 2737-2748, 1988.
32. Good DJ, Polverini PJ, Rastinijad F, Le Beau MM, Lemons RS, Frazier WA and Bouck NP: A tumor suppressor-dependent inhibitor of angiogenesis is immunologically and functionally indistinguishable from a fragment of thrombospondin. Proc Natl Acad Sci USA 87: 6624-6628, 1990.
33. Castle V, Varani J, Fligiel S, Prochownil EV and Dixit VM: Antisense-mediated reduction in thrombospondin reverses the, malignant phenotype of a human squamous carcinoma. J Clin Invest 87: 1883-1888, 1991.
34. Tuszynski GP, Gasic TB, Rothman VL, Knudsen KA and Gasic GJ: Thrombospondin, a potentiator of tumor cell metastasis. Cancer Res 47: 4130-4133, 1987.
35. Cicresszko RE, Guan Z, Stokes BT, Petroff BK, Ottobre AC and Ottobre JS: Arachidonic acid inhibits hCG-stimulated progesterone production by corpora lutea of primates: Potentiel mechanism of action. Prostaglandins 50: 103-119, 1995.
36. Greenwalt DE and Mather IH: Characterization of an apically derived epithelial glycoprotein from bovine milk, which is expressed in capillary endothelia in diverse tissues. J Cell Biol 100: 397-408, 1985.
37. Greenwalt DE, Watt KWK, So Yo and Jiwani N: PAS IV, an integral membrane protein of mammary epithelial cells, is related to platelet and endothelial cell CD36. Biochemistry 29: 7054-7059, 1990.
38. Brandt R, Pepperle M. Otto A, Kraft R, Boehmer FD and Grosse R: A 13-kD protein purified from milk fat globule membrane is closely related to a mammary-derived growth inhibitor. Biochemistry 27: 1420-1425, 1988.